Cablivi
NDC 58468-0225, caplacizumab, kit, from Genzyme Corporation.
- Product NDC
- 58468-0225
- Status
- Listed
- Labeler
- Genzyme Corporation
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761112
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58468-0225-1 | 58468022501 | 1 KIT in 1 CARTON (58468-0225-1) * 1 mL in 1 VIAL, GLASS (58468-0227-1) * 1 mL in 1 SYRINGE, GLASS (58468-0229-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2348f06e-8004-4040-832e-e9e86a39f905
Use it
Look up 58468-0225 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0225 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58468-0225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.